La Red. Mexican Emerging Infectious Disease Clinical Research Network

On April 12, 2009, Mexico responded to a request for verification by the World Health Organization (WHO) of an outbreak of acute respiratory illness in the small community of La Gloria, Veracruz. During April 15-17, 2009, the Mexico Ministry of Health received informal notification of clusters of rapidly progressive severe pneumonia occurring mostly in Distrito Federal (metropolitan Mexico City) and San Luis Potosi.

In response to the outbreak and its consequences, the Ministry of Health of the United Mexican States (MoH) identified the need to develop a coordinated emerging infectious disease research program across Mexico.

Toward this end, a Mexican clinical research network, 'La Red' was initiated in September 2009 between The National Institues of Allergy and Infectios Diseases (NIAID), USA and the Mexican MoH. This Network was created to conduct collaborative clinical research addressing emerging threats, increase scientific knowledge, and directly contribute to improved clinical management of infectious diseases of public health importance.

On April 12, 2009, Mexico responded to a request for verification by the World Health Organization (WHO) of an outbreak of acute respiratory illness in the small community of La Gloria, Veracruz. During April 15-17, 2009, the Mexico Ministry of Health received informal notification of clusters of rapidly progressive severe pneumonia occurring mostly in Distrito Federal (metropolitan Mexico City) and San Luis Potosi.

In response to the outbreak and its consequences, the Ministry of Health of the United Mexican States (MoH) identified the need to develop a coordinated emerging infectious disease research program across Mexico.

Toward this end, a Mexican clinical research network, 'La Red' was initiated in September 2009 between The National Institues of Allergy and Infectios Diseases (NIAID), USA and the Mexican MoH. This Network was created to conduct collaborative clinical research addressing emerging threats, increase scientific knowledge, and directly contribute to improved clinical management of infectious diseases of public health importance.

­